JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist
  • 168
  • -2-1.18%
20min DelayMarket Closed Dec 11 15:30 JST
7.27BMarket Cap-6.17P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
Operating cash flow (Indirect Method)
Cash from operating activities
-728.14%-870.7M
86.47%-105.14M
-69.70%-776.84M
-457.78M
Net profit before non-cash adjustment
-193.49%-1.13B
51.53%-384.2M
-25.62%-792.62M
---630.97M
Total adjustment of non-cash items
40.08%352.28M
2,467.57%251.48M
-119.58%-10.62M
--54.26M
-Depreciation and amortization
----
----
--0
--12.81M
-Reversal of impairment losses recognized in profit and loss
----
----
--0
--26.36M
-Disposal profit
--0
--0
--0
----
-Net exchange gains and losses
109.56%440K
---4.6M
--0
----
-Other non-cash items
37.39%351.84M
2,510.88%256.08M
-170.40%-10.62M
--15.09M
Changes in working capital
-445.86%-95.39M
4.47%27.58M
-77.80%26.4M
--118.94M
-Change in receivables
-233.00%-70.54M
5,038.27%53.04M
-100.58%-1.07M
--185.59M
-Change in inventory
-5,034.59%-16.98M
-95.17%344K
171.05%7.12M
---10.02M
-Change in prepaid assets
90.80%-2.37M
-214.49%-25.8M
227.54%22.54M
---17.67M
-Change in payables
59.05%-3.46M
-131.36%-8.44M
280.07%26.91M
---14.95M
-Change in accrued expense
-100.47%-45K
250.09%9.62M
-53.06%2.75M
--5.85M
-Changes in other current assets
-70.36%-2M
96.31%-1.17M
-6.62%-31.84M
---29.86M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities)
16.22%43K
27.59%37K
61.11%29K
18K
Tax refund paid
-0.67%-2.42M
-617.61%-2.4M
-100.21%-335K
157.11M
Other operating cash inflow (outflow)
-100.61%-2K
16,400.00%330K
0.00%2K
2K
Operating cash flow
-714.62%-873.08M
86.21%-107.18M
-158.49%-777.14M
---300.65M
Investing cash flow
Net changes in other investments
---5.32M
----
---4.03M
----
Investing cash flow
---5.32M
--0
---4.03M
--0
Financing cash flow
Net common stock issuance
403.30%2.51B
-79.01%498.32M
138.24%2.37B
--996.35M
Issuance fees
-4,644.83%-594.95M
---12.54M
--0
----
Net other fund-raising expenses
----
--1.84M
----
----
Financing cash flow
292.34%1.91B
-79.46%487.62M
138.24%2.37B
--996.35M
Net cash flow
Beginning cash position
9.19%4.52B
62.50%4.14B
37.56%2.55B
--1.85B
Current changes in cash
171.97%1.03B
-76.11%380.44M
128.90%1.59B
--695.7M
End cash Position
22.89%5.56B
9.19%4.52B
62.50%4.14B
--2.55B
Free cash flow
-714.62%-873.08M
86.21%-107.18M
-158.49%-777.14M
---300.65M
Currency Unit
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020
Operating cash flow (Indirect Method)
Cash from operating activities -728.14%-870.7M86.47%-105.14M-69.70%-776.84M-457.78M
Net profit before non-cash adjustment -193.49%-1.13B51.53%-384.2M-25.62%-792.62M---630.97M
Total adjustment of non-cash items 40.08%352.28M2,467.57%251.48M-119.58%-10.62M--54.26M
-Depreciation and amortization ----------0--12.81M
-Reversal of impairment losses recognized in profit and loss ----------0--26.36M
-Disposal profit --0--0--0----
-Net exchange gains and losses 109.56%440K---4.6M--0----
-Other non-cash items 37.39%351.84M2,510.88%256.08M-170.40%-10.62M--15.09M
Changes in working capital -445.86%-95.39M4.47%27.58M-77.80%26.4M--118.94M
-Change in receivables -233.00%-70.54M5,038.27%53.04M-100.58%-1.07M--185.59M
-Change in inventory -5,034.59%-16.98M-95.17%344K171.05%7.12M---10.02M
-Change in prepaid assets 90.80%-2.37M-214.49%-25.8M227.54%22.54M---17.67M
-Change in payables 59.05%-3.46M-131.36%-8.44M280.07%26.91M---14.95M
-Change in accrued expense -100.47%-45K250.09%9.62M-53.06%2.75M--5.85M
-Changes in other current assets -70.36%-2M96.31%-1.17M-6.62%-31.84M---29.86M
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
Interest received (cash flow from operating activities) 16.22%43K27.59%37K61.11%29K18K
Tax refund paid -0.67%-2.42M-617.61%-2.4M-100.21%-335K157.11M
Other operating cash inflow (outflow) -100.61%-2K16,400.00%330K0.00%2K2K
Operating cash flow -714.62%-873.08M86.21%-107.18M-158.49%-777.14M---300.65M
Investing cash flow
Net changes in other investments ---5.32M-------4.03M----
Investing cash flow ---5.32M--0---4.03M--0
Financing cash flow
Net common stock issuance 403.30%2.51B-79.01%498.32M138.24%2.37B--996.35M
Issuance fees -4,644.83%-594.95M---12.54M--0----
Net other fund-raising expenses ------1.84M--------
Financing cash flow 292.34%1.91B-79.46%487.62M138.24%2.37B--996.35M
Net cash flow
Beginning cash position 9.19%4.52B62.50%4.14B37.56%2.55B--1.85B
Current changes in cash 171.97%1.03B-76.11%380.44M128.90%1.59B--695.7M
End cash Position 22.89%5.56B9.19%4.52B62.50%4.14B--2.55B
Free cash flow -714.62%-873.08M86.21%-107.18M-158.49%-777.14M---300.65M
Currency Unit JPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Topcon
7732
2656.5 +23.19%
TEMONA
3985
226 +19.58%
Forside
2330
167 +18.44%
Okamoto Glass
7746
216 +17.39%
Delta-Fly Pharma
4598
676 +17.36%

See the daily top gainer.